First published 10/7/2026, 3:12:15 PM · Last updated 10/7/2026, 3:12:15 PM

FuturePHARMA to bridge scientific discoveries gap

The CSIR FuturePHARMA facility was launched in Tshwane to help advance scientific discoveries into pharmaceutical products. The source says South Africa imports about 98% of the active pharmaceutical ingredients used to make medicines locally.

Categories: positive-progress, public-health, technology, economy-and-trade

Generated scores

Scores are based on the cited reporting and use a 1–10 scale. Read the methodology.

Confidence: 6/10How certain the assessment is based on the clarity and evidence in the cited reporting.
Geographic reach: 4/10How widely the event reaches, from a local area (1) to worldwide impact (10).
Global importance: 3/10The event's broader significance, from limited importance (1) to major global importance (10).
Impact magnitude: 3/10The scale or severity of the real-world impact, from minor (1) to extreme (10).
Positivity: 6/10How harmful or beneficial the event is, from strongly harmful (1) to strongly positive (10).
Urgency: 1/10How time-sensitive the event is, from low urgency (1) to immediate attention needed (10).

Why it matters

The facility aims to strengthen the path from pharmaceutical research to testing and manufacturing amid South Africa’s reliance on imported active ingredients.

Location

Sources

FuturePHARMA to bridge scientific discoveries gap

Report an issue